Literature DB >> 26902116

Development of exosome surface display technology in living human cells.

Zachary Stickney1, Joseph Losacco2, Sophie McDevitt3, Zhiwen Zhang4, Biao Lu5.   

Abstract

Surface display technology is an emerging key player in presenting functional proteins for targeted drug delivery and therapy. Although a number of technologies exist, a desirable mammalian surface display system is lacking. Exosomes are extracellular vesicles that facilitate cell-cell communication and can be engineered as nano-shuttles for cell-specific delivery. In this study, we report the development of a novel exosome surface display technology by exploiting mammalian cell secreted nano-vesicles and their trans-membrane protein tetraspanins. By constructing a set of fluorescent reporters for both the inner and outer surface display on exosomes at two selected sites of tetraspanins, we demonstrated the successful exosomal display via gene transfection and monitoring fluorescence in vivo. We subsequently validated our system by demonstrating the expected intracellular partitioning of reporter protein into sub-cellular compartments and secretion of exosomes from human HEK293 cells. Lastly, we established the stable engineered cells to harness the ability of this robust system for continuous production, secretion, and uptake of displayed exosomes with minimal impact on human cell biology. In sum, our work paved the way for potential applications of exosome, including exosome tracking and imaging, targeted drug delivery, as well as exosome-mediated vaccine and therapy.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CD63; CD81; CD9; Exosome; Surface display

Mesh:

Substances:

Year:  2016        PMID: 26902116     DOI: 10.1016/j.bbrc.2016.02.058

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  43 in total

Review 1.  Re-Engineering Extracellular Vesicles as Smart Nanoscale Therapeutics.

Authors:  James P K Armstrong; Margaret N Holme; Molly M Stevens
Journal:  ACS Nano       Date:  2017-01-09       Impact factor: 15.881

Review 2.  Microfluidic engineering of exosomes: editing cellular messages for precision therapeutics.

Authors:  Qingfu Zhu; Mikala Heon; Zheng Zhao; Mei He
Journal:  Lab Chip       Date:  2018-06-12       Impact factor: 6.799

3.  Exosomes as drug delivery vehicle and contributor of resistance to anticancer drugs.

Authors:  Mahendran Chinnappan; Akhil Srivastava; Narsireddy Amreddy; Mohammad Razaq; Vipul Pareek; Rebaz Ahmed; Meghna Mehta; Jo Elle Peterson; Anupama Munshi; Rajagopal Ramesh
Journal:  Cancer Lett       Date:  2020-05-19       Impact factor: 8.679

4.  Engineering Extracellular Vesicles for Cancer Therapy.

Authors:  Christina Nedeva; Suresh Mathivanan
Journal:  Subcell Biochem       Date:  2021

Review 5.  Emerging role of exosomes in hematological malignancies.

Authors:  Sureshbabu Ram Kumar Pandian; Kevin Kumar Vijayakumar; Selvaraj Kunjiappan; Ewa Babkiewicz; Piotr Maszczyk
Journal:  Clin Exp Med       Date:  2022-07-07       Impact factor: 3.984

6.  Bovine mammary alveolar MAC-T cells afford a tool for studies of bovine milk exosomes in drug delivery.

Authors:  Mojisola Ogunnaike; Haichuan Wang; Janos Zempleni
Journal:  Int J Pharm       Date:  2021-11-04       Impact factor: 5.875

7.  Generation of Novel Diagnostic and Therapeutic Exosomes to Detect and Deplete Protumorigenic M2 Macrophages.

Authors:  Mohammad Harun Rashid; Thaiz F Borin; Roxan Ara; Ahmet Alptekin; Yutao Liu; Ali S Arbab
Journal:  Adv Ther (Weinh)       Date:  2020-05-04

8.  A versatile platform for generating engineered extracellular vesicles with defined therapeutic properties.

Authors:  Kevin Dooley; Russell E McConnell; Ke Xu; Nuruddeen D Lewis; Sonya Haupt; Madeleine R Youniss; Shelly Martin; Chang Ling Sia; Christine McCoy; Raymond J Moniz; Olga Burenkova; Jorge Sanchez-Salazar; Su Chul Jang; Bryan Choi; Rane A Harrison; Damian Houde; Dalia Burzyn; Charan Leng; Katherine Kirwin; Nikki L Ross; Jonathan D Finn; Leonid Gaidukov; Kyriakos D Economides; Scott Estes; James E Thornton; John D Kulman; Sriram Sathyanarayanan; Douglas E Williams
Journal:  Mol Ther       Date:  2021-01-21       Impact factor: 11.454

Review 9.  Mesenchymal Stromal Cells-Derived Exosome and the Roles in the Treatment of Traumatic Brain Injury.

Authors:  Yee Yik Mot; Emmanuel Jairaj Moses; Narazah Mohd Yusoff; King-Hwa Ling; Yoke Keong Yong; Jun Jie Tan
Journal:  Cell Mol Neurobiol       Date:  2022-02-01       Impact factor: 5.046

10.  Sequential deletion of CD63 identifies topologically distinct scaffolds for surface engineering of exosomes in living human cells.

Authors:  Natalie Curley; Daniel Levy; Mai Anh Do; Annie Brown; Zachary Stickney; Gerard Marriott; Biao Lu
Journal:  Nanoscale       Date:  2020-06-11       Impact factor: 7.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.